Silence Therapeutics PLC (SLNCF) — SC 13G/A Filings
All SC 13G/A filings from Silence Therapeutics PLC. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Aug 2, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Goldman Sachs Amends Silence Therapeutics Stake on Dec 29 Event
— Feb 12, 2024 Risk: low
Goldman Sachs Group Inc. filed an amended SC 13G/A on February 12, 2024, indicating a change in their beneficial ownership of Silence Therapeutics plc's America -
Artal International S.C.A. Affirms Significant Stake in Silence Therapeutics
— Feb 9, 2024 Risk: low
Artal International S.C.A. and its associated entities, including Artal Group S.A. and Invus Public Equities, L.P., filed an amended Schedule 13G/A on February
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX